Xtant Medical

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$32,357
$33,255
$35,411
$32,904
Gross Profit
17,754
21,992
24,284
20,243
EBITDA
4,135
3,630
5,978
2,152
EBIT
2,316
2,469
4,809
1,078
Net Income
57
1,308
3,550
58
Net Change In Cash
32,357
33,255
35,411
32,904
Free Cash Flow
4,985
4,182
910
87
Cash
17,053
10,400
6,923
5,032
Basic Shares
150,462
148,574
148,574
143,335

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$133,927
$117,267
$91,303
$57,969
Gross Profit
84,273
68,216
55,467
32,137
EBITDA
15,895
-7,878
5,075
-5,428
EBIT
10,672
-12,102
1,901
-6,724
Net Income
4,973
-16,449
660
-8,485
Net Change In Cash
133,927
117,267
91,303
57,969
Cost of Revenue
2,120
Free Cash Flow
10,164
-16,009
-10,971
-7,105
Cash
17,053
6,199
5,715
20,298
Basic Shares
150,042
133,665
126,793
94,085

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
-$0.01
2025-09-30
$0.01
2025-06-30
$0.02